# OnCo record nct04590963 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04590963/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04590963", "NCT04590963" ;
  schema:name "Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer"@en ;
  schema:alternateName "INTERLINK-1"@en ;
  schema:description "A phase 3 trial testing Monalizumab in head and neck squamous cell carcinoma, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04590963/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04590963> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2020-10-02" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:drugs <https://onco.cc/drugs/monalizumab/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .